Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II

被引:36
|
作者
Sumner, AT [1 ]
机构
[1] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1007/s004120050333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diplochromosomes, consisting of four chromatids lying side-by-side, instead of the normal two, are produced when cells go through two rounds of DNA replication without separation of chromatids. They are thus an indication of the failure of the normal chromosome separation mechanism. In the present experiments, induction of diplochromosomes by inhibitors of topoisomerase II (Topo II) was used to provide further evidence that Topo LI is required for separation of daughter chromosomes. Actively growing cultures of CHO cells were treated with Colcemid, and separated into metaphase and interphase fractions, each of which was treated for 2 h with the Topo II inhibitor being tested. The cells were then cultivated in fresh medium without inhibitor for periods of between 18 and 44 h, and metaphase cells once again accumulated by treatment with Colcemid. Chromosome preparations were made in the standard way and stained with Giemsa. Up to 2,000 metaphases were counted from each culture, and the proportion with diplochromosomes calculated. At appropriate concentrations, the Topo II inhibitors etoposide and mitoxantrone induced substantial levels of metaphases with diplochromosomes in cultures that had been treated when the cells were in interphase (up to 30% and 11%, respectively). Amsacrine, however, only produced a smaller proportion (4.7%) of metaphases with diplochromosomes after a much longer culture period following treatment. All the inhibitors caused severe chromosome damage. When used to treat metaphase cells, mitoxantrone and amsacrine only induced diplochromosomes after prolonged culture, although a small number of diplochromosomes were seen after etoposide treatment and a shorter period of culture. Results with cells treated in metaphase might indicate that Topo II is, in fact, not required for anaphase chromosome separation, although it is clearly important for segregation of newly replicated DNA.
引用
收藏
页码:486 / 490
页数:5
相关论文
共 50 条
  • [31] INDUCTION OF MAMMALIAN TOPOISOMERASE-II DEPENDENT DNA CLEAVAGE BY NONINTERCALATIVE FLAVONOIDS, GENISTEIN AND OROBOL
    YAMASHITA, Y
    KAWADA, SZ
    NAKANO, H
    BIOCHEMICAL PHARMACOLOGY, 1990, 39 (04) : 737 - 744
  • [32] Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells
    Wray, Justin
    Williamson, Elizabeth A.
    Royce, Melanie
    Shaheen, Montaser
    Beck, Brian D.
    Lee, Suk-Hee
    Nickoloff, Jac A.
    Hromas, Robert
    PLOS ONE, 2009, 4 (04):
  • [33] INDUCTION OF MAMMALIAN DNA TOPOISOMERASE-II DEPENDENT DNA CLEAVAGE BY ANTITUMOR ANTIBIOTIC STREPTONIGRIN
    YAMASHITA, Y
    KAWADA, SZ
    FUJII, N
    NAKANO, H
    CANCER RESEARCH, 1990, 50 (18) : 5841 - 5844
  • [34] Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons
    Makhey, D
    Gatto, B
    Yu, CA
    Liu, A
    Liu, LF
    LaVoie, EJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (06) : 781 - 791
  • [35] ALTERED DNA TOPOISOMERASE ACTIVITY IN CHINESE-HAMSTER CELLS RESISTANT TO TOPOISOMERASE-II INHIBITORS
    KERRIGAN, D
    SCHWARTZ, R
    SWACK, J
    MCCURDY, A
    POMMIER, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 264 - 264
  • [36] Catalytic inhibitors of DNA topoisomerase II
    Andoh, T
    Ishida, R
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 155 - 171
  • [37] Drug resistance to topoisomerase II inhibitors
    Robert, J
    Larsen, AK
    BIOCHIMIE, 1998, 80 (03) : 247 - 254
  • [38] INDUCTION OF THE DIFFERENTIATION OF WEHI-3B D+ MONOMYELOCYTIC LEUKEMIA-CELLS BY INHIBITORS OF TOPOISOMERASE-II
    RAPPA, G
    LORICO, A
    SARTORELLI, AC
    CANCER RESEARCH, 1990, 50 (20) : 6723 - 6730
  • [39] Topoisomerase IIβ mediates the cytotoxicity of topoisomerase II poisons in the presence of HDAC inhibitors.
    Marchion, DC
    Bicaku, E
    Turner, JG
    Daud, AI
    Sullivan, DM
    Munster, PN
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9021S - 9021S
  • [40] QUINOBENOXAZINES - A CLASS OF NOVEL ANTITUMOR QUINOLONES AND POTENT MAMMALIAN DNA TOPOISOMERASE-II CATALYTIC INHIBITORS
    PERMANA, PA
    SNAPKA, RM
    SHEN, LL
    CHU, DTW
    CLEMENT, JJ
    PLATTNER, JJ
    BIOCHEMISTRY, 1994, 33 (37) : 11333 - 11339